3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
1
Interventions
Methotrexate
3
olokizumab
2
veltuzumab
1
upadacitinib
1
tocilizumab
1
mavrilimumab
1
golimumab
1
andecaliximab
1
Vaccines
1
Tumor Necrosis Factor Inhibitors
1
TACI receptor-IgG Fc fragment fusion protein
1
Saline Solution
1
RC-18
1
Interleukin 1 Receptor Antagonist Protein
1
ISIS104838
1
Herpes Zoster Vaccine
1
Bortezomib
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Arthritis, Rheumatoid
×
veltuzumab
×
Clear all
NCT01390545
2016-04-13
VELVET
Takeda
Phase 2
Terminated
300 enrolled